购物车
您的购物车当前为空
别名 费妥赛仑, SAR-439774, SAR439774, SAR 439774, ALN-AT3SC
Fitusiran(ALN-AT3SC)是一种小干扰 RNA 治疗分子,旨在选择性结合肝脏中抗凝血酶的信使 RNA,从而持续降低抗凝血酶的生成并增强凝血酶产生,为血友病模型中恢复止血平衡提供了一种具有机制创新性的研究途径。


为众多的药物研发团队赋能,
让新药发现更简单!
Fitusiran(ALN-AT3SC)是一种小干扰 RNA 治疗分子,旨在选择性结合肝脏中抗凝血酶的信使 RNA,从而持续降低抗凝血酶的生成并增强凝血酶产生,为血友病模型中恢复止血平衡提供了一种具有机制创新性的研究途径。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 987 | 现货 | |
| 5 mg | ¥ 2,620 | 现货 | |
| 10 mg | ¥ 4,580 | 现货 | |
| 25 mg | ¥ 6,930 | 现货 | |
| 50 mg | ¥ 9,530 | 现货 | |
| 100 mg | ¥ 12,800 | 现货 |
| 产品描述 | Fitusiran (ALN-AT3SC) is a small interfering RNA therapeutic designed to selectively bind antithrombin messenger RNA in the liver, leading to sustained reduction of antithrombin production and enhanced thrombin generation, thereby offering a mechanistically innovative research approach for restoring hemostatic balance in hemophilia models. |
| 别名 | 费妥赛仑, SAR-439774, SAR439774, SAR 439774, ALN-AT3SC |
| 分子量 | 16248.2(AS:7675+SS:8573.2) |
| CAS No. | 1499251-18-1 |
| 密度 | no data available |
| Sequence | RNA, ((2'-deoxy-2'-fluoro)G-sp-Gm-sp-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Am- (2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)A-Um-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)A),3'-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-Dgalactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate], complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)U-sp-Gm-(2'-deoxy2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)G-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)A-Um-Gm-Gm-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Am-(2'-deoxy-2'-fluoro)C-Cm-sp-Am-sp-Gm) |
| 存储 | |
| 溶解度信息 | H2O: 40.00 mg/mL, Sonication is recommended. |
对于不同动物的给药剂量换算,您也可以参考 更多